Reversal by the MER tubercle bacillus fraction of the suppressive effects of heterologous antilymphocytic serum (ALS) on the allograft reactivity of mice.
D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D001500:BCG Vaccine; D002478:Cells, Cultured; D002859:Chromium Isotopes; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D012515:Mast-Cell Sarcoma / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D009169:Mycobacterium tuberculosis / Q000276:immunology*; D013154:Spleen / Q000166:cytology; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D001500:BCG Vaccine; D002859:Chromium Isotopes